Rachel S. Goodman

Assessing the Accuracy and Reliability of AI-Generated Medical Responses: An Evaluation of the Chat-GPT Model

L. Chambless, J. Zic, Travis J. Osterman, 2023, Research square.

On the cusp: Considering the impact of artificial intelligence language models in healthcare.

J. Patrinely, Travis Osterman, Rachel S Goodman, 2023, Med.

Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities

Douglas B. Johnson, J. Balko, Seungyeon Jung, 2023, Immunological reviews.

Long-term outcomes of chronic immune-related adverse events from adjuvant anti-PD-1 therapy for high-risk resected melanoma.

Douglas B. Johnson, I. Osman, G. Long, 2023, Journal of Clinical Oncology.

Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort Study

Seungyeon Jung, Rachel S. Goodman, Kylie Fletcher, 2024, Cancers.

Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma

Douglas B. Johnson, I. Osman, G. Long, 2023, JAMA network open.